Literature Highlights

Each month the Steering Committee selects the latest published original articles on immune-mediated inflammatory diseases, focusing on those with data on therapeutic interventions and those that have clinical impact.

↩ Back to Literature Highlights

PsO Literature Highlights - Historic publications

Keywords:

adalimumab, apremilast, bimekizumab, brodalumab, Certolizumab, deucravacitinib, efficacy, guselkumab, ixekizumab, mirikizumab, phase 2, phase 3, placebo, plaque psoriasis, risankizumab, secukinumab, scalp psoriasis, ustekinumab